Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Vertex Medical Devices (Jiangsu) Co., Ltd.
Dingdian Medical Devices (Jiangsu) Co., Ltd. was established in 2006 and is affiliated to BASS Medical Group. For many years, Dingdian Medical has focused on the field of diabetes and is committed to providing patients with lifelong services for diabetes treatment, so as to help patients relieve pain, restore health and prolong their lives as their corporate mission. Dingdian Medical’s management comes from a well-known company in the world’s top 500 companies and has many years of experience in the medical device industry and a global vision. The R&D team has a group of rigorous software and hardware engineers and polymer material technicians. They have a thorough understanding of drug infusion equipment and maintain close contact with many experts in the medical field, well-known universities, research institutions, hospitals and other units in China. technical cooperation and resource sharing. Currently, they have more than 20 domestic and foreign patents. Since 2011, Dingdian Medical has begun to develop its overseas sales network. The company's main products include insulin pumps and various supporting consumables. Currently, it has own brand sales networks in many countries such as Italy, Austria, Russia, Turkey, Egypt, Greece, India, etc. In addition, Dingdian Medical also provides technical support and OEM/ODM services to many world-renowned pharmaceutical companies and medical institutions to meet customers' personalized needs. Dingdian Medical has always adhered to the principle of "quality first and strive for excellence", and provides patients with appropriate insulin intensive treatment solutions with continuous technological innovation, focusing on sugar control services, and sharing a healthy life!
Vertex Medical Devices (Jiangsu) Co., Ltd.
Dingdian Medical Devices (Jiangsu) Co., Ltd. was established in 2006 and is affiliated to BASS Medical Group. For many years, Dingdian Medical has focused on the field of diabetes and is committed to providing patients with lifelong services for diabetes treatment, so as to help patients relieve pain, restore health and prolong their lives as their corporate mission. Dingdian Medical’s management comes from a well-known company in the world’s top 500 companies and has many years of experience in the medical device industry and a global vision. The R&D team has a group of rigorous software and hardware engineers and polymer material technicians. They have a thorough understanding of drug infusion equipment and maintain close contact with many experts in the medical field, well-known universities, research institutions, hospitals and other units in China. technical cooperation and resource sharing. Currently, they have more than 20 domestic and foreign patents. Since 2011, Dingdian Medical has begun to develop its overseas sales network. The company's main products include insulin pumps and various supporting consumables. Currently, it has own brand sales networks in many countries such as Italy, Austria, Russia, Turkey, Egypt, Greece, India, etc. In addition, Dingdian Medical also provides technical support and OEM/ODM services to many world-renowned pharmaceutical companies and medical institutions to meet customers' personalized needs. Dingdian Medical has always adhered to the principle of "quality first and strive for excellence", and provides patients with appropriate insulin intensive treatment solutions with continuous technological innovation, focusing on sugar control services, and sharing a healthy life!
Beijing Maishtong Technology Co., Ltd.
Beijing Maisitong Technology Co., Ltd. is a high-tech enterprise specializing in the research and development, production, sales and services of insulin pumps. The company was jointly founded by Dr. Ma Yanhui, a scientist studying in the United States, and European and American investors. Dr. Ma has been conducting cutting-edge scientific research on diabetes in the United States for a long time and is committed to introducing innovative products and technologies in the international diabetes treatment field to China to serve Chinese patients. After years of research and development by Sino-US joint research team, the company has successfully developed the "Maishtong" insulin intelligent infusion system composed of Maishtong insulin pump, disposable insulin pump reservoir and infusion device, and has obtained the national Registration and approval by the Food and Drug Administration (CFDA). Maiston’s goal is to enable more Chinese diabetic patients to understand and use insulin pumps, helping them actively and effectively control their blood sugar and improve their quality of life. Compared with other similar products on the market, Maiston insulin pumps are simple and easy to use and cost-effective. They have developed and designed some unique functions according to the characteristics and needs of Chinese patients. I believe these functions will make Maiston. Insulin pumps are accepted and used by more people. Maistone independently developed and controlled the entire production process from insulin pumps to consumables, and can provide more competitive prices and timely and thoughtful and multi-faceted customer services, so that diabetic patients can "afford and affordable," he said. Use it well”, truly benefiting from insulin pump treatment. Maiston is determined to become a popularizer in China's insulin pump market. It will adhere to the goal of domestic product production, scientific and technological innovation as a means, and combine Internet thinking and innovative service models to help patients better control sugar and move towards health. At the same time, it also contributes little to the development and growth of China's medical technology.
Beijing Maishtong Technology Co., Ltd.
Beijing Maisitong Technology Co., Ltd. is a high-tech enterprise specializing in the research and development, production, sales and services of insulin pumps. The company was jointly founded by Dr. Ma Yanhui, a scientist studying in the United States, and European and American investors. Dr. Ma has been conducting cutting-edge scientific research on diabetes in the United States for a long time and is committed to introducing innovative products and technologies in the international diabetes treatment field to China to serve Chinese patients. After years of research and development by Sino-US joint research team, the company has successfully developed the "Maishtong" insulin intelligent infusion system composed of Maishtong insulin pump, disposable insulin pump reservoir and infusion device, and has obtained the national Registration and approval by the Food and Drug Administration (CFDA). Maiston’s goal is to enable more Chinese diabetic patients to understand and use insulin pumps, helping them actively and effectively control their blood sugar and improve their quality of life. Compared with other similar products on the market, Maiston insulin pumps are simple and easy to use and cost-effective. They have developed and designed some unique functions according to the characteristics and needs of Chinese patients. I believe these functions will make Maiston. Insulin pumps are accepted and used by more people. Maistone independently developed and controlled the entire production process from insulin pumps to consumables, and can provide more competitive prices and timely and thoughtful and multi-faceted customer services, so that diabetic patients can "afford and affordable," he said. Use it well”, truly benefiting from insulin pump treatment. Maiston is determined to become a popularizer in China's insulin pump market. It will adhere to the goal of domestic product production, scientific and technological innovation as a means, and combine Internet thinking and innovative service models to help patients better control sugar and move towards health. At the same time, it also contributes little to the development and growth of China's medical technology.
Kailian Medical Technology (Shanghai) Co., Ltd.
Kailianle Pump® Insulin Pump Intelligently control sugar, enjoy life, and believe that diabetes management can become very simple, and use technology and services to provide Chinese people with affordable insulin pumps. The specifications and model of Kailianle Pump® insulin pump are ATA-I-1, which adopts rechargeable lithium iron phosphate battery and OLED color screen. The main menu displays color icons + text, and data transmission is carried out through BLE Bluetooth. It is equipped with the Micro-Discovery APP. Bluetooth connects blood glucose meter and Lep pump to achieve closed-loop cloud management. Simple and easy to use: automatic distribution of basic rates is quick and worry-free, flexible setting of large doses is easy to deal with, and OLED color screen + UI graphics are clear and easy to understand. Smart and easy to use: the pump is not left to the body to view the device information intelligently, the data is synchronized and the blood sugar management in the hospital is orderly, and the sharing of data information is convenient for the care of relatives and friends. Economical and practical: the equipment and consumables are affordable, the capacitive point-to-touch operation is durable, and the "five hearts" service is professional and worry-free. Kailian Medical Technology (Shanghai) Co., Ltd. (hereinafter referred to as "Kailian Medical") was established in 2014. Relying on a R&D and technical team with more than 15 years of experience, it will provide trace infusion product technology with independent intellectual property rights.与基于硬件开发的移动互联云管理平台结合，为糖尿病、内分泌慢性病、不孕不育相关患者提供从诊断、治疗到照护的全生命周期决绝方案。 Kailian Medical’s vision is to become an innovative micro-drug infusion system research and development and chronic disease health management solution platform enterprise. Kailian Medical’s mission is to provide cost-effective treatment solutions for chronic patients and create a better life; to build a good life for employees.的工作氛围和成长环境；为合作伙伴和股东创造价值。
Kailian Medical Technology (Shanghai) Co., Ltd.
Kailianle Pump® Insulin Pump Intelligently control sugar, enjoy life, and believe that diabetes management can become very simple, and use technology and services to provide Chinese people with affordable insulin pumps. The specifications and model of Kailianle Pump® insulin pump are ATA-I-1, which adopts rechargeable lithium iron phosphate battery and OLED color screen. The main menu displays color icons + text, and data transmission is carried out through BLE Bluetooth. It is equipped with the Micro-Discovery APP. Bluetooth connects blood glucose meter and Lep pump to achieve closed-loop cloud management. Simple and easy to use: automatic distribution of basic rates is quick and worry-free, flexible setting of large doses is easy to deal with, and OLED color screen + UI graphics are clear and easy to understand. Smart and easy to use: the pump is not left to the body to view the device information intelligently, the data is synchronized and the blood sugar management in the hospital is orderly, and the sharing of data information is convenient for the care of relatives and friends. Economical and practical: the equipment and consumables are affordable, the capacitive point-to-touch operation is durable, and the "five hearts" service is professional and worry-free. Kailian Medical Technology (Shanghai) Co., Ltd. (hereinafter referred to as "Kailian Medical") was established in 2014. Relying on a R&D and technical team with more than 15 years of experience, it will provide trace infusion product technology with independent intellectual property rights.与基于硬件开发的移动互联云管理平台结合，为糖尿病、内分泌慢性病、不孕不育相关患者提供从诊断、治疗到照护的全生命周期决绝方案。 Kailian Medical’s vision is to become an innovative micro-drug infusion system research and development and chronic disease health management solution platform enterprise. Kailian Medical’s mission is to provide cost-effective treatment solutions for chronic patients and create a better life; to build a good life for employees.的工作氛围和成长环境；为合作伙伴和股东创造价值。
MicroPort Scientific Corporation
Micro-Invasive was founded in Zhangjiang Science City, Shanghai, China in 1998. It is an innovative medical device group, in Shanghai, Suzhou, Jiaxing, Shenzhen, China; Irvine, Memphis, Boston, USA ; Paris, France ; Milan, Italy ; Aachen, Germany ; Oxford, UK; Santo Domingo, Dominican ; Mumbai, India and San Jose, Costa Rica and other places have built major production (R&D) bases, forming a global R&D, production, marketing and service network. In the minimally invasive family, more than 12,000 employees from more than 30 countries are committed to providing patients around the world with universal truth, goodness and beauty solutions that can extend and reshape lives, thereby helping hundreds of millions of earthlings to cross the 115-year-old lifeline. More than 400 products have been launched in minimally invasive products, covering cardiovascular and structural heart disease, electrophysiological and cardiac rhythm management systems, bone and soft tissue repair technology, major arterial and peripheral vascular diseases, cerebrovascular and neuroregulatory science, surgical critical illness and robotics , endocrine management and assisted reproduction, urology and gynecological digestive and respiratory diseases, otolar and nose, mouth and eyes, etc., in vitro diagnosis and internal and external imaging, in vivo solid tumor treatment technology, insomnia and depression and rehabilitation medical twelve major business clusters. Minimally invasive products have entered more than 20,000 hospitals in more than 100 countries around the world. On average, one minimally invasive product is used every 6 seconds to treat patients' lives or improve their quality of life or to help them. Give new life.
MicroPort Scientific Corporation
Micro-Invasive was founded in Zhangjiang Science City, Shanghai, China in 1998. It is an innovative medical device group, in Shanghai, Suzhou, Jiaxing, Shenzhen, China; Irvine, Memphis, Boston, USA ; Paris, France ; Milan, Italy ; Aachen, Germany ; Oxford, UK; Santo Domingo, Dominican ; Mumbai, India and San Jose, Costa Rica and other places have built major production (R&D) bases, forming a global R&D, production, marketing and service network. In the minimally invasive family, more than 12,000 employees from more than 30 countries are committed to providing patients around the world with universal truth, goodness and beauty solutions that can extend and reshape lives, thereby helping hundreds of millions of earthlings to cross the 115-year-old lifeline. More than 400 products have been launched in minimally invasive products, covering cardiovascular and structural heart disease, electrophysiological and cardiac rhythm management systems, bone and soft tissue repair technology, major arterial and peripheral vascular diseases, cerebrovascular and neuroregulatory science, surgical critical illness and robotics , endocrine management and assisted reproduction, urology and gynecological digestive and respiratory diseases, otolar and nose, mouth and eyes, etc., in vitro diagnosis and internal and external imaging, in vivo solid tumor treatment technology, insomnia and depression and rehabilitation medical twelve major business clusters. Minimally invasive products have entered more than 20,000 hospitals in more than 100 countries around the world. On average, one minimally invasive product is used every 6 seconds to treat patients' lives or improve their quality of life or to help them. Give new life.
Viat Medical (Hangzhou) Co., Ltd.
Weitai Medical Devices (Hangzhou) Co., Ltd. is a pioneer in the field of diabetes management medical devices. Through innovation and integration of diabetes treatment and monitoring technologies, it has been able to reshape the new model of diabetes management in China and globally. The company was established in 2011 and is headquartered in Hangzhou Future Science and Technology City, a high-level overseas talent innovation park in Zhejiang Province. It has been designated as the Key Enterprise Research Institute of Diabetes Testing and Treatment Equipment in Zhejiang Province, China, and has also established a R&D center in Silicon Valley. Weitai Medical has a strong internal R&D team composed of nearly 100 members, including scholars, scientists, elite engineers and experienced experts from world-renowned universities. More than 30% of the R&D members have master's or doctoral degrees. The company's main R&D personnel have an average of 13 years of relevant R&D experience, and more than a dozen R&D personnel have worked in well-known medical device companies. Weitai Medical focuses on technological innovation in the field of diabetes management medical devices, and is committed to promoting the company's products to the global market.
Viat Medical (Hangzhou) Co., Ltd.
Weitai Medical Devices (Hangzhou) Co., Ltd. is a pioneer in the field of diabetes management medical devices. Through innovation and integration of diabetes treatment and monitoring technologies, it has been able to reshape the new model of diabetes management in China and globally. The company was established in 2011 and is headquartered in Hangzhou Future Science and Technology City, a high-level overseas talent innovation park in Zhejiang Province. It has been designated as the Key Enterprise Research Institute of Diabetes Testing and Treatment Equipment in Zhejiang Province, China, and has also established a R&D center in Silicon Valley. Weitai Medical has a strong internal R&D team composed of nearly 100 members, including scholars, scientists, elite engineers and experienced experts from world-renowned universities. More than 30% of the R&D members have master's or doctoral degrees. The company's main R&D personnel have an average of 13 years of relevant R&D experience, and more than a dozen R&D personnel have worked in well-known medical device companies. Weitai Medical focuses on technological innovation in the field of diabetes management medical devices, and is committed to promoting the company's products to the global market.
Zhengzhou Ruiyu Technology Co., Ltd.
Ruiyu Technology was founded in March 2007. After years of focused development, it has become an endocrine medical technology company integrating high-tech R&D, high-quality production, and high-service marketing. It is committed to providing complete treatment for patients with diabetes and pituitary diseases. plan. The company's R&D and marketing center is located in Shenzhen. In this frontier position full of innovative practices, Ruiyu has formed a strong R&D team. The team is led by industry experts, most of the talents have doctoral and master's degrees, and brings together many polymer, hardware and software, and artificial intelligence experts. The team maintains close technical sharing relationships with research institutions, hospitals and universities in relevant fields at home and abroad, ensuring the advanced nature of Ruiyu equipment. The UP 310 insulin pump developed by Ruiyu is an insulin pump with Bluetooth connection function. With the support of cloud APP, intelligent sugar control becomes possible, providing doctors with big data diagnosis and treatment plans, and providing patients with various index statistics and feedback. Greatly improve the treatment level. In 2021, the Henan Provincial Department of Finance and the Department of Science and Technology issued a notice on the annual innovation and entrepreneurship team project approval and funding funds, and provided project approval support for Ruiyu Medical's R&D and Industrialization of "New Insulin Pump R&D and Industrialization". This is an important affirmation of the company's R&D and innovation capabilities. Ruiyu Marketing Center is formed by professional sales talents. The sales partners are not only pioneering and professional, but also have a sense of mission to be responsible to patients and a sense of responsibility to become sugar-treating experts. Do your best to think about the patients. Sales performance has steadily increased, maintaining the forefront of the domestic market. Ruiyu's production base is located in the Airport Biomedical Park of Zhengzhou Airport, Henan Province. The park is a large-scale life science and biotechnology research and development, production innovation and entrepreneurship base under construction in Henan Province. The company has advanced production equipment and complete testing methods, and implements ISO13485:2016 and GMP certification in management. Every detail of Ruiyu's production strives to excel from procurement, assembly line, quality management, logistics and after-sales service. The company adheres to the business philosophy of "service, innovation, quality and responsibility", and unremittingly pursues advanced technology and excellent products. It insists on doing things steadily, being innovative, pragmatic and trustworthy, and living happily, bringing cost-effective endocrine equipment to every corner of the world. , is the common vision of all Ruiyu people.
Zhengzhou Ruiyu Technology Co., Ltd.
Ruiyu Technology was founded in March 2007. After years of focused development, it has become an endocrine medical technology company integrating high-tech R&D, high-quality production, and high-service marketing. It is committed to providing complete treatment for patients with diabetes and pituitary diseases. plan. The company's R&D and marketing center is located in Shenzhen. In this frontier position full of innovative practices, Ruiyu has formed a strong R&D team. The team is led by industry experts, most of the talents have doctoral and master's degrees, and brings together many polymer, hardware and software, and artificial intelligence experts. The team maintains close technical sharing relationships with research institutions, hospitals and universities in relevant fields at home and abroad, ensuring the advanced nature of Ruiyu equipment. The UP 310 insulin pump developed by Ruiyu is an insulin pump with Bluetooth connection function. With the support of cloud APP, intelligent sugar control becomes possible, providing doctors with big data diagnosis and treatment plans, and providing patients with various index statistics and feedback. Greatly improve the treatment level. In 2021, the Henan Provincial Department of Finance and the Department of Science and Technology issued a notice on the annual innovation and entrepreneurship team project approval and funding funds, and provided project approval support for Ruiyu Medical's R&D and Industrialization of "New Insulin Pump R&D and Industrialization". This is an important affirmation of the company's R&D and innovation capabilities. Ruiyu Marketing Center is formed by professional sales talents. The sales partners are not only pioneering and professional, but also have a sense of mission to be responsible to patients and a sense of responsibility to become sugar-treating experts. Do your best to think about the patients. Sales performance has steadily increased, maintaining the forefront of the domestic market. Ruiyu's production base is located in the Airport Biomedical Park of Zhengzhou Airport, Henan Province. The park is a large-scale life science and biotechnology research and development, production innovation and entrepreneurship base under construction in Henan Province. The company has advanced production equipment and complete testing methods, and implements ISO13485:2016 and GMP certification in management. Every detail of Ruiyu's production strives to excel from procurement, assembly line, quality management, logistics and after-sales service. The company adheres to the business philosophy of "service, innovation, quality and responsibility", and unremittingly pursues advanced technology and excellent products. It insists on doing things steadily, being innovative, pragmatic and trustworthy, and living happily, bringing cost-effective endocrine equipment to every corner of the world. , is the common vision of all Ruiyu people.
Zhuhai Funiya Medical Equipment Co., Ltd.
Zhuhai Fornia Medical Equipment Co., Ltd. was established in May 2000 and is located on the coast of science and technology innovation in Zhuhai High-tech Zone. It has now developed into a research and development and manufacturing enterprise for medical device consumables and equipment with strong technical strength and brand influence. The Phase I, Phase II and Phase III of Fornia covers an area of more than 60,000 square meters and the factory building area reaches 55,000 square meters. The company has high-end and sophisticated production equipment and testing instruments, excellent technical equipment, complete testing methods, and ranks among the forefront of the domestic industry in the same industry. It has the ability to manufacture various high-end medical consumables and equipment. The company's products mainly involve two major areas: anesthesia consumables manufacturing and endocrine treatment, including disposable infusion pumps, insulin pumps, electronic micropumps, disposable central venous catheter packs, disposable anesthesia puncture packs, disposable sterile throat masks , disposable sterile tracheal intubation, disposable bronchial occlusion device and more than 20 medical device products. The company actively participates in global competition and is involved in international trade. Its products are exported to the EU, Australia, Japan, Russia, Southeast Asian countries and the Middle East and other regions. The company has a R&D system composed of doctoral, master's, undergraduate and senior engineers. Relying on the extensive clinical awareness of medical experts, it leverages the scientific research innovation of high-tech talents in the industry and establishes it with universities and research institutions and other units. Cooperation relationships, development of cooperative advantages. The company has built a research and development and production base with excellent technical equipment, perfect testing methods, and advanced process technology in the same industry in China. The company's mission is to provide hospitals and patients with cost-effective medical equipment and services, care for public health, and create a better future. The company's vision is to grow into a well-known medical equipment company with international competitiveness, making Fornia an indispensable benefit to human healthy life and create value for customers, employees, shareholders and society.
Zhuhai Funiya Medical Equipment Co., Ltd.
Zhuhai Fornia Medical Equipment Co., Ltd. was established in May 2000 and is located on the coast of science and technology innovation in Zhuhai High-tech Zone. It has now developed into a research and development and manufacturing enterprise for medical device consumables and equipment with strong technical strength and brand influence. The Phase I, Phase II and Phase III of Fornia covers an area of more than 60,000 square meters and the factory building area reaches 55,000 square meters. The company has high-end and sophisticated production equipment and testing instruments, excellent technical equipment, complete testing methods, and ranks among the forefront of the domestic industry in the same industry. It has the ability to manufacture various high-end medical consumables and equipment. The company's products mainly involve two major areas: anesthesia consumables manufacturing and endocrine treatment, including disposable infusion pumps, insulin pumps, electronic micropumps, disposable central venous catheter packs, disposable anesthesia puncture packs, disposable sterile throat masks , disposable sterile tracheal intubation, disposable bronchial occlusion device and more than 20 medical device products. The company actively participates in global competition and is involved in international trade. Its products are exported to the EU, Australia, Japan, Russia, Southeast Asian countries and the Middle East and other regions. The company has a R&D system composed of doctoral, master's, undergraduate and senior engineers. Relying on the extensive clinical awareness of medical experts, it leverages the scientific research innovation of high-tech talents in the industry and establishes it with universities and research institutions and other units. Cooperation relationships, development of cooperative advantages. The company has built a research and development and production base with excellent technical equipment, perfect testing methods, and advanced process technology in the same industry in China. The company's mission is to provide hospitals and patients with cost-effective medical equipment and services, care for public health, and create a better future. The company's vision is to grow into a well-known medical equipment company with international competitiveness, making Fornia an indispensable benefit to human healthy life and create value for customers, employees, shareholders and society.
Hengsheng Medical Technology Co., Ltd.
Hengsheng Medical Technology Co., Ltd. is based in the medical device industry and has been focusing on the professional hospital market since its establishment. It is a closed-loop monitoring, treatment and blood sugar management for patients with diabetes. The service provider of solutions. The company's main business is the research and development, production and sales of blood sugar monitoring and diabetes management products, medical consumables and reagents. At present, the company has built two R&D centers in Hangzhou and Zhuhai, and has built three product production bases in Urumqi, Hangzhou and Zhuhai, forming a multi-regional linkage business development pattern. After more than ten years of continuous development, the company's main product sales have covered more than 20 provinces and cities across the country. Hengsheng Medicine is committed to the research and development and production of biosensing technology-related products. It has its own brand "Doctor Doctor" series of products and has the "Hengsheng Big Health" APP. It currently uses blood sugar detection system, blood sugar management system, dynamic blood sugar monitoring system, The blood sugar management and treatment series of products such as insulin pumps and various biochemical reagents are mainly used in clinical testing. The accuracy and stability of the product quality have been recognized by domestic and foreign testing institutions. It is a domestic patient with chronic diseases such as diabetes. Companies that provide closed-loop treatment solutions for the entire industry chain products. Hengsheng Medicine focuses on being a good chronic disease management product and a professional hospital service provider in China. It currently maintains good cooperative relationships with more than 3,000 hospitals across the country, and its product sales are all over the country. The company takes "giving everyone a healthy body and a beautiful life" as its corporate vision, and continues to pursue, contribute and win-win situation in the field of medicine. Hengsheng Medicine sincerely hopes to work hand in hand with knowledgeable people at home and abroad to create a better tomorrow.
Hengsheng Medical Technology Co., Ltd.
Hengsheng Medical Technology Co., Ltd. is based in the medical device industry and has been focusing on the professional hospital market since its establishment. It is a closed-loop monitoring, treatment and blood sugar management for patients with diabetes. The service provider of solutions. The company's main business is the research and development, production and sales of blood sugar monitoring and diabetes management products, medical consumables and reagents. At present, the company has built two R&D centers in Hangzhou and Zhuhai, and has built three product production bases in Urumqi, Hangzhou and Zhuhai, forming a multi-regional linkage business development pattern. After more than ten years of continuous development, the company's main product sales have covered more than 20 provinces and cities across the country. Hengsheng Medicine is committed to the research and development and production of biosensing technology-related products. It has its own brand "Doctor Doctor" series of products and has the "Hengsheng Big Health" APP. It currently uses blood sugar detection system, blood sugar management system, dynamic blood sugar monitoring system, The blood sugar management and treatment series of products such as insulin pumps and various biochemical reagents are mainly used in clinical testing. The accuracy and stability of the product quality have been recognized by domestic and foreign testing institutions. It is a domestic patient with chronic diseases such as diabetes. Companies that provide closed-loop treatment solutions for the entire industry chain products. Hengsheng Medicine focuses on being a good chronic disease management product and a professional hospital service provider in China. It currently maintains good cooperative relationships with more than 3,000 hospitals across the country, and its product sales are all over the country. The company takes "giving everyone a healthy body and a beautiful life" as its corporate vision, and continues to pursue, contribute and win-win situation in the field of medicine. Hengsheng Medicine sincerely hopes to work hand in hand with knowledgeable people at home and abroad to create a better tomorrow.
Asante Snap insulin pumps are known for their affordability and simplicity, making them accessible to a wide range of users.
Asante Solutions, Inc.
Asante Snap insulin pumps are known for their affordability and simplicity, making them accessible to a wide range of users.
SOOIL Development Co., Ltd.
SOOIL's Dana insulin pumps are compact and lightweight, offering reliable insulin delivery for diabetes patients.
SOOIL Development Co., Ltd.
SOOIL's Dana insulin pumps are compact and lightweight, offering reliable insulin delivery for diabetes patients.
Cellnovo provides a mobile-connected insulin pump system that integrates with smartphones for real-time diabetes management.
Cellnovo Group
Cellnovo provides a mobile-connected insulin pump system that integrates with smartphones for real-time diabetes management.
Johnson & Johnson (formerly)
Animas was a well-known brand for insulin pumps, offering advanced features like waterproof designs, before its discontinuation in
Johnson & Johnson (formerly)
Animas was a well-known brand for insulin pumps, offering advanced features like waterproof designs, before its discontinuation in
Ypsomed's mylife™ insulin pumps are designed for simplicity and precision, offering customizable solutions for diabetes patients.
Ypsomed AG
Ypsomed's mylife™ insulin pumps are designed for simplicity and precision, offering customizable solutions for diabetes patients.
Roche's Accu-Chek brand includes insulin pumps and diabetes management tools, known for their reliability and user-friendly features.
Roche Diabetes Care
Roche's Accu-Chek brand includes insulin pumps and diabetes management tools, known for their reliability and user-friendly features.
Insulet's Omnipod is a tubeless insulin pump system that offers flexibility and ease of use for people with diabetes, featuring a discreet and wearable design.
Insulet Corporation
Insulet's Omnipod is a tubeless insulin pump system that offers flexibility and ease of use for people with diabetes, featuring a discreet and wearable design.
Tandem Diabetes Care, Inc.
Tandem Diabetes Care specializes in innovative insulin pumps like the t:slim X2, which integrates with CGM systems to provide personalized diabetes management.
Tandem Diabetes Care, Inc.
Tandem Diabetes Care specializes in innovative insulin pumps like the t:slim X2, which integrates with CGM systems to provide personalized diabetes management.
Medtronic MiniMed is a leading provider of insulin pumps and continuous glucose monitoring (CGM) systems, offering advanced diabetes management solutions for patients worldwide.
Medtronic plc
Medtronic MiniMed is a leading provider of insulin pumps and continuous glucose monitoring (CGM) systems, offering advanced diabetes management solutions for patients worldwide.
Dexcom specializes in continuous glucose monitoring systems, providing real-time glucose data for diabetes management.
Dexcom, Inc.
Dexcom specializes in continuous glucose monitoring systems, providing real-time glucose data for diabetes management.
DreaMed offers AI-based insulin pump optimization tools, helping patients and healthcare providers improve diabetes management.
DreaMed Diabetes Ltd.
DreaMed offers AI-based insulin pump optimization tools, helping patients and healthcare providers improve diabetes management.
